These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18481434)

  • 21. (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3292-7. PubMed ID: 17452102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.
    Giardinà D; Martarelli D; Sagratini G; Angeli P; Ballinari D; Gulini U; Melchiorre C; Poggesi E; Pompei P
    J Med Chem; 2009 Aug; 52(15):4951-4. PubMed ID: 19719240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha(1)-adrenoceptor antagonists.
    Soman AD; Gogtay JA
    BJU Int; 2006 Jan; 97(1):198. PubMed ID: 16336361
    [No Abstract]   [Full Text] [Related]  

  • 24. Region and age dependent differences in alpha(1)-adrenergic responsiveness of rat seminal vesicle and vas deferens.
    Yono M; Latifpour J; Yamamoto Y; Imanishi A; Yoshida M
    Eur J Pharmacol; 2008 Jun; 587(1-3):291-5. PubMed ID: 18472093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].
    Yang MG; Zhao XK
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):830-4. PubMed ID: 17929564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of alpha-adrenoceptors in male sexual function.
    Rampin O
    Eur Urol; 1999; 36 Suppl 1():103-6. PubMed ID: 10393482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erectile dysfunction and lower urinary tract.
    Sandner P; Neuser D; Bischoff E
    Handb Exp Pharmacol; 2009; (191):507-31. PubMed ID: 19089343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ejaculatory dysfunction and alpha-adrenoceptor antagonists.
    Michel MC
    BJU Int; 2004 Aug; 94(3):443-4; author reply 444-5. PubMed ID: 15291886
    [No Abstract]   [Full Text] [Related]  

  • 29. Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses.
    Nargund VH; Grey AD
    Expert Opin Pharmacother; 2008 Apr; 9(5):813-24. PubMed ID: 18345957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ejaculatory disorders and sexual function.
    Ralph DJ; Wylie KR
    BJU Int; 2005 Jun; 95(9):1181-6. PubMed ID: 15892797
    [No Abstract]   [Full Text] [Related]  

  • 32. Can smooth muscle represent a useful target for the treatment of rapid ejaculation?
    Abdel-Hamid IA
    Drug Discov Today; 2005 Nov; 10(21):1459-66. PubMed ID: 16243266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):640-4. PubMed ID: 18055202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K
    Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ejaculatory dysfunction: progress in rarely acknowledged sexual problems.
    Seftel A
    Int J Impot Res; 2006; 18 Suppl 1():S1-2. PubMed ID: 16953243
    [No Abstract]   [Full Text] [Related]  

  • 36. Erectile function, sexual drive, and ejaculatory function alter reconstructive surgery for anterior urethral stricture disease.
    de León JP
    BJU Int; 2007 Jun; 99(6):1549. PubMed ID: 17537225
    [No Abstract]   [Full Text] [Related]  

  • 37. Intraoperative floppy iris syndrome associated with alpha1-adrenergic receptor antagonists.
    Cantrell MA; Bream-Rouwenhorst HR; Steffensmeier A; Hemerson P; Rogers M; Stamper B
    Ann Pharmacother; 2008 Apr; 42(4):558-63. PubMed ID: 18364408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography.
    Nagai A; Hara R; Yokoyama T; Jo Y; Fujii T; Miyaji Y
    Int J Urol; 2008 Oct; 15(10):915-918. PubMed ID: 18721206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
    Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ejaculatory dysfunction: progress in a rarely recognized sexual problem.
    Carson CC
    Int J Impot Res; 2006; 18 Suppl 1():S3-4. PubMed ID: 16953245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.